Clinical Trials Browser

Patient Reported Outcome Measures × Plasma cell × Clear all

COVID-19, Multiple Myeloma, Neoplasms, Plasma Cell

NCT04663100 2023-12-04

Oral Adherence in Hematological Oncology Agents and Impact on Comorbid Therapy Adherence

LymphoidMyeloidOther hematologic neoplasmOther neoplasmPlasma cell

Multiple Chronic Conditions, Leukemia, Multiple Myeloma, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Hematologic Neoplasms

Clinical Trials

COSMIC

Oral Adherence in Hematological Oncology Agents and Impact on Comorbid Therapy Adherence